214 related articles for article (PubMed ID: 25197358)
1. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic implications of CD8
Zou MX; Guo KM; Lv GH; Huang W; Li J; Wang XB; Jiang Y; She XL
Cancer Immunol Immunother; 2018 Feb; 67(2):209-224. PubMed ID: 29051990
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155 expression is independently predictive of outcome in chordoma.
Osaka E; Kelly AD; Spentzos D; Choy E; Yang X; Shen JK; Yang P; Mankin HJ; Hornicek FJ; Duan Z
Oncotarget; 2015 Apr; 6(11):9125-39. PubMed ID: 25823817
[TBL] [Abstract][Full Text] [Related]
5. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
6. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.
Chen H; Zhang K; Wu G; Song D; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.
Xu F; Zhang H; Su Y; Kong J; Yu H; Qian B
Clin Transl Oncol; 2014 Nov; 16(11):980-5. PubMed ID: 24805982
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
9. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
Gao Y; Zhang SG; Wang ZH; Liao JC
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2098-2102. PubMed ID: 28537676
[TBL] [Abstract][Full Text] [Related]
13. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
15. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
16. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
[TBL] [Abstract][Full Text] [Related]
18. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
19. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]